Monthly Archives: June 2012

DePuy ASR Hip Replacement Lawsuit Update – DePuy ASR Lawsuit Status Conference Set For July 25, 2012

Leave a reply

Gilman Law LLP, a national law firm representing individuals with DePuy ASR hip replacements, reports that on June 11, 2012, the Honorable David A. Katz, who is overseeing In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation (“MDL No. 2197”), currently underway in the U.S. District Court for the Northern District of Ohio, issued an order scheduling the next status conference in the DePuy ASR MDL for July 25, 2012.

Metal Hip Replacement Bellwether Trials In DePuy ASR Hip Lawsuit To Be Scheduled

A DePuy ASR Lawsuit status conference was previously held on June 5, 2012. Counsel updated the Judge on the discovery process, the production of documents, the status of depositions, and the coordination between the Federal DePuy ASR Hip Lawsuits and State DePuy ASR Hip Lawsuits. The DePuy ASR Hip Attorneys are actively working to schedule bellwether trials in the DePuy ASR Hip Implant Lawsuit. The first federal bellwether trial is expected to take place in Spring 2013. While the first state court trial is scheduled to take place in Nevada in December 2012. Another state court trial set for January 2013 in Maryland.

Gilman Law LLP Continues To File Metal-On-Metal Hip Replacement Lawsuits

In addition to actively filing DePuy hip replacement lawsuits in the DePuy ASR MDL, the hip lawyers at Gilman Law LLP are also filing lawsuits on behalf of individuals who have been implanted with certain metal-on-metal DePuy Pinnacle hip replacements, in In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation (“MDL No. 2244”). The firm is also investigating cases concerning Wright Medical Technology, Inc. metal hip implant Lawsuits involving the Wright Conserve hip replacements. These Wright metal hip implant lawsuits were recently consolidated in In re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation (“MDL No. 2409”).

Metal Hip Implant Lawsuit Attorney

If you or a loved one has experienced metal hip implant side effects, you may be entitled to compensation for medical expenses, pain and suffering, lost wages, and further injuries. To learn more about how to file a DePuy Hip Implant Lawsuit, please contact our medical device attorneys:

About the DePuy Hip Implant Lawyers at Gilman Law LLP

Gilman Law LLP is a nationally recognized law firm representing individuals in complex injury cases in areas such as dangerous drugs, defective medical devices, DePuy Hip Implants, and other defective or dangerous consumer products.

Actos Lawsuit Update: Doctor Group Sours on Actos in Favor of Older Diabetes Meds

Leave a reply

Further developments in the Actos lawsuit as the medical community appears to be growing cautious of Actos (Pioglitazone), Takeda Pharmaceutical’s best selling type-2 diabetes drug. Nearly a year after the U.S. Food & Drug Administration (FDA) and other regulators worldwide warned that Actos might be associated with an increased risk of bladder cancer, at least one U.S. doctor group has cautioned patients against it.

Last month, the American College of Physicians advised that patients steer clear of expensive, new diabetes drugs like Actos, and opt instead for more “tried and true” medications such as generic metformin. A new brochure put out by the College in cooperation with Consumer Reports points out that not only is generic metformin less expensive than Actos and other newer drugs, “it lowers blood sugar levels more than newer drugs do.” It also reduces “bad cholesterol,” while newer medications don’t.

Risks of Actos Bladder Cancer

Actos Bladder Cancer Lawsuit Update

Actos Bladder Cancer Lawsuit Update

Actos, made by Takeda Pharmaceuticals, is one of the best selling type-2 diabetes drugs in the world. But June of 2011, the FDA, as well as regulators in Europe and Canada, warned that studies had shown that long-term use of Actos can increase the risk of bladder cancer by as much as 40%. New warnings were added to the U.S. and Canadian labels for Actos. In France, however, the drug was actually recalled.

Since the Actos bladder cancer warnings were issued, Actos has been named in an avalanche of U.S. lawsuits. Some legal experts say Takeda may face as many as 10,000 claims over bladder cancer and other Actos side effects. Late last year, federal Actos lawsuits were consolidated in a multidistrict litigation and transferred to Louisiana. The case is known as In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).

About the Defective Drug Attorneys of Gilman Law LLP

Gilman Law LLP, a leading national law firm, represents victims of Actos side effects, including bladder cancer. Find out more about the Actos Lawsuit on our website for the Actos Bladder Cancer Lawsuit. If you or a loved one were injured by Actos, please contact our firm as follows for a free consultation and Actos Case Review:

Contact an Actos Bladder Cancer Attorney for an Actos Lawsuit